SCHEDULE 13GAccepted Mar 3, 4:05 PM ET
Zentalis Pharmaceuticals, Inc. SCHEDULE 13G
Accepted (ET)
4:05 PM
Mar 3, 2026
Filed
Mar 3, 2026
Documents
2
Size
80.9 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.